As previously reported [4,6,10], PAH patients carrying a BMPR2 mutation were significantly younger at diagnosis than non-carriers (35.8 ± 15.4 and 47.5 ± 16.2, p < 0.0001). The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.